Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated according to Medscape policies. Others involved in the planning of this activity have no relevant financial relationships.
Faculty
-
Brian Berman, MD, PhD
Professor Emeritus
Dermatology and Cutaneous Surgery
University of Miami Miller School of Medicine
Miami, Florida
-
Adam Friedman, MD, FAAD
Professor and Chair of Dermatology
George Washington University
School of Medicine & Health Sciences
Washington, DC
-
Todd Schlesinger, MD, FAAD
Director
Clinical Research Center of the Carolinas
Charleston, South Carolina
Editors
Compliance Reviewer/Nurse Planner
Peer Reviewer
This activity has been peer reviewed and the reviewer has no relevant financial relationships.
CME / ABIM MOC / CE
Patient-Centric Management of Actinic Keratosis
- Authors: Brian Berman, MD, PhD; Adam Friedman, MD, FAAD; Todd Schlesinger, MD, FAAD
- CME / ABIM MOC / CE Released: 3/25/2024
- Valid for credit through: 3/25/2025, 11:59 PM EST
-
-
Credits Available
Physicians - maximum of 1.00 AMA PRA Category 1 Credit(s)™
ABIM Diplomates - maximum of 1.00 ABIM MOC points
Nurses - 1.00 ANCC Contact Hour(s) (0.25 contact hours are in the area of pharmacology)
You Are Eligible For
- Letter of Completion
- ABIM MOC points
Target Audience and Goal Statement
This activity is intended for dermatologists, nurse practitioners, physician assistants, primary care physicians, and other clinicians who treat patients with AK.
The goal of this activity is for learners to be better able to implement patient-centered strategies when considering the various treatment options for AK, including awareness of the efficacy, safety, and patient-reported outcomes for available agents.
Upon completion of this activity, participants will:
- Have increased knowledge regarding the
- Different treatment approaches for AK
- Safety and tolerability of AK therapies in relationship to treatment adherence
- Have greater competence related to
- Integrating evidence-based AK treatment strategies into practice
- Demonstrate greater confidence in their ability to
- Engage in shared decision-making with patients for the selection of AK therapy
Disclosures
Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated according to Medscape policies. Others involved in the planning of this activity have no relevant financial relationships.
Faculty
-
Brian Berman, MD, PhD
Professor Emeritus
Dermatology and Cutaneous Surgery
University of Miami Miller School of Medicine
Miami, Florida
-
Adam Friedman, MD, FAAD
Professor and Chair of Dermatology
George Washington University
School of Medicine & Health Sciences
Washington, DC
-
Todd Schlesinger, MD, FAAD
Director
Clinical Research Center of the Carolinas
Charleston, South Carolina
Editors
Compliance Reviewer/Nurse Planner
Peer Reviewer
This activity has been peer reviewed and the reviewer has no relevant financial relationships.
Accreditation Statements
In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
-
Medscape, LLC designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.
College of Family Physicians of Canada Mainpro+® participants may claim certified credits for any AMA PRA Category 1 credit(s)™, up to a maximum of 50 credits per five-year cycle. Any additional credits are eligible as non-certified credits. College of Family Physicians of Canada (CFPC) members must log into Mainpro+® to claim this activity.
Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “CME in Support of MOC” program in Section 3 of the Royal College’s MOC Program.
For Physicians
-
Awarded 1.0 contact hour(s) of nursing continuing professional development for RNs and APNs; 0.25 contact hours are in the area of pharmacology.
For Nurses
For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]
Instructions for Participation and Credit
There are no fees for participating in or receiving credit for this online educational activity. For information on applicability
and acceptance of continuing education credit for this activity, please consult your professional licensing board.
This activity is designed to be completed within the time designated on the title page; physicians should claim only those
credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the
activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.
Follow these steps to earn CME/CE credit*:
- Read about the target audience, learning objectives, and author disclosures.
- Study the educational content online or print it out.
- Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.
You may now view or print the certificate from your CME/CE Tracker. You may print the certificate, but you cannot alter it.
Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period, you can print
out the tally as well as the certificates from the CME/CE Tracker.
*The credit that you receive is based on your user profile.
Patient-Centric Management of Actinic Keratosis
CME / ABIM MOC / CE Released: 3/25/2024
Valid for credit through: 3/25/2025, 11:59 PM EST
processing....
Learning Feedback Questions
Please answer the questions below to self-assess your knowledge. Answering these questions again after the activity will allow you to see what you learned.
